1q12 pericentric heterochromatin, 159
Aβ receptor, 289
Adrenoleukodystrophy, 90
Aging, 388
Alveolar epithelium, 26
Alzheimer's disease, 247, 306
Amyloid, 306
Amyloid-beta (Aβ), 289
Angiogenesis, 516
Angiotensin II, 247
Annexin A1, 401
AP-1, 211
Apc, 472
Apoptosis, 51, 294, 415, 490
Arthritis, 172
ASK1, 504
Atherosclerosis, 79
Aurora-A, 130
Autoimmune disease, 247
Autoimmunity, 172
Axonal transport, 42
β-agonist, 26
β-thalassemia, 291
B cell lymphoma, 159
Bcr/Abl, 98
Blood pressure, 63
Braf, 458
Breast cancer, 3
Cancer, 6, 130, 146, 338, 516
Cancer mutation screening, 143
Cancer stem cells, 371
CD4+ T cells, 231
Cell cycle, 338
Chemokines, 504
Chromatin, 6
Chronic immune activation, 231
Colon cancer, 440
Colorectal cancer, 472
Cristae remodelling, 490
Deep-sequencing, 143
Demyelination, 504
Dendritic cells, 231
Dequalinium, 371
Diabetes, 196, 338
Differentiation, 16
Distal tubule, 39
Diuretic, 39
DNA damage, 415
DNA repair, 130
DNA-PKcs, 415
Drug, 429
Dynamic nuclear polarization, 196
Dynamics, 487
Elastase, 26
Elongase, 90
ELOVL, 90
EMCV, 275
EMT, 401
Endothelial, 516
Epigenetics, 6, 120, 335
ERAB, 51
FAK, 516
Fission, 487, 490
Foamy macrophage, 258
Friedreich ataxia (FRDA), 120
Fusion, 487
Gene therapy, 291, 315
Genomics, 3
Genotyping, 146
Glia, 504
GMCL1, 159
Granuloma, 258
Growth factor, 294
Haematopoiesis, 291
Haematopoietic stem cells, 315
Haemoglobin, 315
Hedgehog-Gli, 440
Hepatectomy, 294
Herpes viruses, 231
Heterochromatic foci, 159
Heterochromatic gene silencing, 120
HIF, 275
HIF-1, 211
High-throughput screen, 371
Histone modification, 120
HIV pathogenesis, 231
HMGB1, 193
HSD10, 51
Huntington's disease, 335, 349, 487, 490
Hypertension, 39
Individualized therapy, 143
Inflammation, 172, 189, 193, 247
Insertional mutagenesis, 291
Insulin, 189
Intestine, 458
Ion cotransporters, 63
Lentiviral vectors, 315
Lentivirus, 291
Leukaemia, 98
Leukaemic stem cells, 98
Liver regeneration, 294
Locus control region, 315
Longevity, 247
Magnetic resonance imaging, 196
Magnetic resonance spectroscopy, 196
Metabolism, 338
Metastasis, 211, 440
Metastasis suppressor, 401
Mitochondria, 487, 490
Mitochondrial bioenergetics, 349
Mouse model, 458
Multiple sclerosis, 42
Myc, 16
Mycobacterium, 258
Myelin, 42
Network analysis, 79
Neuroblastoma, 371
Neurodegeneration, 51
Neuropeptide, 429
Neurotoxicity, 289
NF-κB, 275
NPY, 429
Nuclear architecture, 159
Obesity, 196, 338
Oligomers, 289
Oncogene, 16
Organic aciduria, 51
p21, 472
p53, 388
PARP inhibitors, 130
Peroxisome, 90
PGC-1-alpha, 335
Phosphoinositide 3-kinase (PI3K), 189
Prion protein, 306
Prion protein (PrP), 289
Profiling, 146
Proliferation, 294
Prostasin, 26
Proteolipid protein, 42
RAD51, 130
RCC, 275
Receptor, 429
Redox, 388
Renal carcinoma, 472
Rheumatoid arthritis, 415
SDF-1, 211
Secreted phospholipase A2, 172
Senescence, 458, 472
Serrated colorectal cancer, 458
Sestrin, 388
Signal transduction, 63
Signalling, 401
SNaP-shot, 143
Sodium channel, 26
SPAK, 63
Stat3, 401
Stat5, 98
Stem cell, 440
Stem cells, 16
Stroma, 211
Synaptic plasticity, 306
Systems biology, 79
T-cell, 415
Target of rapamycin, 388
Targeted therapies, 146
Therapeutics, 429
TLR4, 193
Toll-like receptors, 504
Toll-like receptors (TLR), 189
Transcription, 335
Transcriptional dysregulation, 349
Transglutaminase, 335, 349
Triplet repeat expansion disorder (TRED), 120
Tuberculosis, 258
Tumour, 516
Tumour initiating cells, 371
Unfolded protein response (UPR), 189
VHL, 275
Visual system, 42
VLCFA, 90
WNK, 39, 63
Wnt-Tcf, 440
X inactivation, 6
Xist RNA, 6
ZDON, 349